Table 1. Clinical demographics of cases and controls for the PBMC-derived macrophage studies.
F, female; M, male.
| ID | Genotype | Diagnosis | Sex | Ethnicity | Age of onset (years) | Age at blood sample (years) | Disease duration (months) | Site of onset | Drug history | Family history |
|---|---|---|---|---|---|---|---|---|---|---|
| Control-1 | Control | – | F | Caucasian | – | 51 | – | – | No | No |
| Control-2 | Control | – | M | Caucasian | – | 42 | – | – | No | No |
| Control-3 | Control | – | F | Caucasian | – | 78 | – | Thyroxine | No | |
| C9-1 | C9orf72 | ALS | F | Caucasian | 52 | 54 | 24 | Lower limb | Riluzole | FTD |
| C9-2 | C9orf72 | Asymptomatic carrier | M | Caucasian | – | 44 | – | – | No | ALS/FTD |
| C9-3 | C9orf72 | FTD | F | Caucasian | 76 | 77 | 84 | – | Amlodipine, atorvastatin | FTD |